KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Edwards Lifesciences' Total Liabilities fell 870.89% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year decrease of 870.89%. This contributed to the annual value of $3.0 billion for FY2024, which is 1318.56% up from last year.
  • Edwards Lifesciences' Total Liabilities amounted to $3.1 billion in Q3 2025, which was down 870.89% from $2.9 billion recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Total Liabilities high stood at $3.4 billion for Q3 2024, and its period low was $2.4 billion during Q3 2022.
  • For the 5-year period, Edwards Lifesciences' Total Liabilities averaged around $2.7 billion, with its median value being $2.6 billion (2024).
  • As far as peak fluctuations go, Edwards Lifesciences' Total Liabilities surged by 2708.7% in 2024, and later plummeted by 870.89% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Total Liabilities (Quarter) stood at $2.7 billion in 2021, then fell by 6.78% to $2.5 billion in 2022, then grew by 6.36% to $2.6 billion in 2023, then rose by 13.19% to $3.0 billion in 2024, then grew by 2.5% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $2.9 billion for Q2 2025, and $2.8 billion during Q1 2025.